The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

The effects of biological disease-modifying antirheumatic drugs (bDMARDs) in the clinical course of COVID-19 on children with underlying rheumatologic diseases have not been fully demonstrated. To evaluate the course of COVID-19 infection in patients with rheumatic disease receiving bDMARD treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Sozeri, Betul, Ulu, Kadir, Kaya-Akça, Ummusen, Haslak, Fatih, Pac-Kisaarslan, Aysenur, Otar-Yener, Gulcin, Baba, Ozge, Altug-Gucenmez, Ozge, Sahin, Nihal, Bağlan, Esra, Sönmez, Hafize Emine, Cakmak, Figen, Ozturk, Kubra, Gezgin-Yıldırım, Deniz, Şener, Seher, Barut, Kenan, Batu, Ezgi Deniz, Yıldız, Mehmet, Basaran, Ozge, Adrovic, Amra, Sahin, Sezgin, Ozdel, Semanur, Bilginer, Yelda, Poyrazoglu, Muammer Hakan, Demir, Ferhat, Yuksel, Selcuk, Kalyoncu, Mukaddes, Kasapcopur, Ozgur, Ozen, Seza, Aktay-Ayaz, Nuray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475421/
https://www.ncbi.nlm.nih.gov/pubmed/34570263
http://dx.doi.org/10.1007/s00296-021-05008-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475421/
https://www.ncbi.nlm.nih.gov/pubmed/34570263
http://dx.doi.org/10.1007/s00296-021-05008-w

Ejemplares similares